Estimación del riesgo de enfermedad cardiovascular ateroesclerótica a 10 años determinado por la calculadora de riesgo de ASCVD en pacientes atendidos en el Servicio de Reumatología del Hospital San Juan de Dios de enero a diciembre del año 2018 con diagnóstico de artritis reumatoide, artritis psoriásica y espondilitis anquilosante
Cargando...
Archivos
Fecha
2019
Autores
Director
Título de la revista
ISSN de la revista
Título del volumen
Publicador
Páginas
Resumen
Antecedentes. Estudios han documentado un riesgo mayor de enfermedad aterosclerótica cardiovascular en pacientes portadores de enfermedades articulares inflamatorias como el caso de la artritis reumatoide, artritis psoriásica y espondilitis anquilosante. Materiales y métodos. Objetivo: calcular el riesgo cardiovascular de enfermedad aterosclerótica a 10 años determinado por la calculadora del Colegio Americano de Cardiología en pacientes con artritis reumatoide, artritis psoriásica y espondilitis anquilosante en control en el servicio de reumatología del Hospital San Juan de Dios. Diseño: estudio observacional, descriptivo de revisión de expedientes clínicos. Escenario: servicio de reumatología en un hospital universitario de nivel terciario. Pacientes: pacientes con diagnóstico de artritis reumatoide, artritis psoriásica y espondilitis anquilosante atendidos en consulta externa de reumatología. Medidas: diagnóstico de artritis reumatoide, psoriásica o espondilitis anquilosante, diagnóstico de comorbilidades de riesgo cardiovascular como diabetes mellitus, hipertensióbn arterial, dislipidemia y tabaquismo, y variables clínicas como cifras de presión arterial, edad, valores de colesterol total, LDL, HDL y fármacos utilizados. Resultados: un 40% del casos posee un riesgo bajo de EACV a 10 años y el restante 60% se encuentra entre los grupo de riesgo limítrofe (17%), con riesgo moderado (32%) y riesgo alto (11%), en donde el subgrupo de pacientes con AP presenta el mayor riesgo respecto a los pacientes con AR y EA. Lo anterior se relaciona con una mayor frecuencia de comorbilidades como hipetensión arterial y diabetes mellitus en dicho subgrupo. Es posible optimizar factores modificables de riesgo para variar la estratificación de riesgo. Limitaciones. Las variables se tomaron de los expedientes clínicos, dependiendo completamente del criterio de los médicos tratantes...
Inglés: Background. An increased risk of cardiovascular atherosclerotic disease has been documented in patients with inflammatory joint diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Materials and methods. Objective: calculate the 10-year cardiovascular risk of atherosclerotic disease determined by the calculator of the American College of Cardiology in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in control in the Rheumatology Department of the San Juan de Dios Hospital. Design: observational study with descriptive review of clinical records. Scenario: rheumatology service in a tertiary level teaching hospital. Patients: patients diagnosed with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis treated as outpatient in the Rheumatology Department Measures. diagnosis of rheumatoid arthritis, psoriatic or ankylosing spondylitis, diagnosis of cardiovascular risk comorbidities such as diabetes mellitus, arterial hypertension, dyslipidemia and smoking, clinical variables blood pressure figures, age, total cholesterol values, LDL, HDL and drugs used. Results: 40% of patients have a low risk of EACV at 10 years and the remaining 60% are among the borderline risk groups (17%), moderate risk (32%) and high risk (11%), being the subgroup of patients with PA the one with the highest risk compared to patients with RA and AD, the foregoing being related to a higher frequency of comorbidities such as arterial hypertension and diabetes mellitus in this subgroup. It is possible to optimize modifiable risk factors to modify the risk stratification. Limitations: The variables were taken from the clinical files, completely depending on the criteria of the treating physicians for the diagnosis of inflammatory joint disease, diabetes mellitus, arterial hypertension and smoking. Conclusions. In patients with RA, PA and AD there is a...
Inglés: Background. An increased risk of cardiovascular atherosclerotic disease has been documented in patients with inflammatory joint diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Materials and methods. Objective: calculate the 10-year cardiovascular risk of atherosclerotic disease determined by the calculator of the American College of Cardiology in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in control in the Rheumatology Department of the San Juan de Dios Hospital. Design: observational study with descriptive review of clinical records. Scenario: rheumatology service in a tertiary level teaching hospital. Patients: patients diagnosed with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis treated as outpatient in the Rheumatology Department Measures. diagnosis of rheumatoid arthritis, psoriatic or ankylosing spondylitis, diagnosis of cardiovascular risk comorbidities such as diabetes mellitus, arterial hypertension, dyslipidemia and smoking, clinical variables blood pressure figures, age, total cholesterol values, LDL, HDL and drugs used. Results: 40% of patients have a low risk of EACV at 10 years and the remaining 60% are among the borderline risk groups (17%), moderate risk (32%) and high risk (11%), being the subgroup of patients with PA the one with the highest risk compared to patients with RA and AD, the foregoing being related to a higher frequency of comorbidities such as arterial hypertension and diabetes mellitus in this subgroup. It is possible to optimize modifiable risk factors to modify the risk stratification. Limitations: The variables were taken from the clinical files, completely depending on the criteria of the treating physicians for the diagnosis of inflammatory joint disease, diabetes mellitus, arterial hypertension and smoking. Conclusions. In patients with RA, PA and AD there is a...
Descripción
Tesis (especialista en reumatología)--Universidad de Costa Rica. Programa de Estudios de Posgrado en Especialidades Médicas, 2019
Palabras clave
ARTRITIS PSORIASICA - PACIENTES - COSTA RICA, ARTRITIS REUMATOIDE - PACIENTES - COSTA RICA, ESPONDILITIS ANQUILOSANTE - PACIENTES - COSTA RICA, SISTEMA CARDIOVASCULAR - ENFERMEDADES, Hospital San Juan de Dios (Costa Rica). Servicio de Reumatología - CASOS, HISTORIAS CLÍNICAS, ESTADISTICAS, ETC.2018